Hematocrit–albumin gap linked to sepsis risk in ICU adults in retrospective analysis
This retrospective cross-sectional analysis used data from the MIMIC-IV database and a Medical Intensive Care Unit in China, involving 19,134 adults in a derivation cohort and 630 in a validation cohort with first-recorded ICU admissions. The study examined the hematocrit–albumin gap (HAG) as an exposure, with sepsis prevalence overall at 54.5% (men 56.1%, women 43.9%).
Main results showed that each 7.848 increment in HAG was associated with a sepsis risk odds ratio of 1.43 (95% CI: 1.37–1.48). HAG below -9.162 had an odds ratio of 0.938, while HAG between -9.162 and 17.27 showed a significant positive correlation with an effect size of 1.051, and HAG above 17.27 indicated a relative saturation effect with an effect size of 1.023. A significant statistical interaction was found between HAG and comorbidities like anemia, liver disease, and metastatic solid tumors (P < 0.05).
Safety and tolerability data were not reported. Key limitations include that diagnostic utility requires prospective validation, and follow-up duration was not reported. The study observed an association without claiming causality, and sensitivity analyses reinforced reliability, but findings should be interpreted cautiously until validated in prospective studies.